| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 101 | $333.06 | -2.05% | +9.22% | $9.86B €8.54B | 64.71K shrs $21.55M | ||
| 102 | ¥117.31 | -1.17% | +1.29% | ¥70.78B $9.77B · €8.46B | 1.42M shrs ¥167M | ||
| 103 | $11.64 | -2.23% | -2.24% | $9.7B €8.40B | 593.17K shrs $6.91M | ||
| 104 | $68.97 | -4.81% | +6.56% | $9.59B €8.30B | 840.33K shrs $57.95M | ||
| 105 | $108.03 | -4.89% | +34.67% | $9.43B €8.16B | 945.55K shrs $102.15M | ||
| 106 | ¥115.43 | -2.13% | +23.51% | ¥65.13B $8.99B · €7.79B | 3.34M shrs ¥385.72M | ||
| 107 | €178.00 | -0.34% | +3.81% | €7.92B $8.64B | 25.81K shrs €4.59M | ||
| 108 | ¥21.81 | -0.64% | +3.86% | ¥58.24B $8.04B · €6.96B | 7.32M shrs ¥159.59M | ||
| 109 | $48.13 | -6.43% | +4.21% | $8B €6.93B | 1.87M shrs $90.24M | ||
| 110 | ¥2238.50 | -5.27% | +2.99% | ¥1.17T $7.85B · €6.80B | 1.23M shrs ¥2.76B | ||
| 111 | $72.62 | -3.03% | +10.81% | $7.8B €6.75B | 740.62K shrs $53.78M | ||
| 112 | kr 239.80 | -1.15% | -4.67% | kr 53.14B $7.76B · €6.72B | 8.24K shrs kr 1.98M | ||
| 113 | €87.85 | +4.65% | +37.19% | €7B $7.63B | 530.62K shrs €46.61M | ||
| 114 | ₹390.00 | -1.27% | -0.75% | ₹635.03B $7.62B · €6.60B | 109.59K shrs ₹42.74M | ||
| 115 | ¥34.61 | +2.15% | +12.44% | ¥55.06B $7.60B · €6.58B | 17.42M shrs ¥602.84M | ||
| 116 | ₹5251.50 | -0.47% | +2.81% | ₹627.9B $7.53B · €6.53B | 143.53K shrs ₹753.74M | ||
| 117 | ₹5251.25 | -0.48% | +3.68% | ₹627.87B $7.53B · €6.53B | 3.85K shrs ₹20.24M | ||
| 118 | HK$3.59 | +0.56% | -6.10% | HK$57.89B $7.41B · €6.42B | 79.51M shrs HK$285.43M | ||
| 119 | ¥47.58 | -2.30% | +37.12% | ¥53.29B $7.35B · €6.37B | 5.11M shrs ¥243.25M | ||
| 120 | ₹2166.20 | -0.66% | -0.80% | ₹611.3B $7.34B · €6.35B | 512.87K shrs ₹1.11B | ||
| 121 | ₹2165.50 | -0.73% | -1.45% | ₹611.11B $7.33B · €6.35B | 45.63K shrs ₹98.81M | ||
| 122 | $6.92 | -5.08% | +25.68% | $7.25B €6.28B | 13.56M shrs $93.83M | ||
| 123 |  Nuvalent, Inc. NUVL🇺🇸USD | $90.95 | -3.27% | +0.13% | $7.18B €6.22B | 707.43K shrs $64.34M | |
| 124 | ¥3775.00 | -1.05% | +7.66% | ¥1.06T $7.14B · €6.18B | 1.77M shrs ¥6.68B | ||
| 125 |  Alkermes plc ALKS🇺🇸USD | $42.80 | -1.34% | +7.59% | $7.13B €6.18B | 1.3M shrs $55.69M | |
| 126 | $254.00 | -4.06% | +4.66% | $7.08B €6.13B | 563.51K shrs $143.13M | ||
| 127 | ¥2225.00 | +1.34% | +2.21% | ¥1.05T $7.01B · €6.07B | 1.65M shrs ¥3.67B | ||
| 128 | ¥28.42 | +2.08% | +2.25% | ¥49.84B $6.88B · €5.96B | 15.1M shrs ¥429.07M | ||
| 129 |  Vaxcyte, Inc. PCVX🇺🇸USD | $47.36 | -2.87% | +7.93% | $6.84B €5.92B | 905.33K shrs $42.88M | |
| 130 | ₩379500.00 | -0.13% | -2.82% | ₩9.44T $6.80B · €5.89B | 10.47K shrs ₩3.98B | ||
| 131 |  Grifols, S.A. GRF.MC🇪🇸EUR | €9.06 | +0.04% | -0.34% | €6.16B $6.72B | 1.8M shrs €16.3M | |
| 132 | ₹26035.00 | +0.83% | -0.08% | ₹553.23B $6.64B · €5.75B | 3.62K shrs ₹94.19M | ||
| 133 | ₹26017.65 | +0.71% | — | ₹552.86B $6.63B · €5.75B | 570 shrs ₹14.83M | ||
| 134 | $100.98 | -1.79% | +2.76% | $6.57B €5.69B | 728.31K shrs $73.54M | ||
| 135 | $86.92 | -4.38% | -0.08% | $6.55B €5.68B | 1.3M shrs $112.91M | ||
| 136 | kr 44.80 | +1.36% | -0.37% | kr 44.45B $6.49B · €5.62B | 993.12K shrs kr 44.49M | ||
| 137 | $73.65 | -6.15% | -8.41% | $6.4B €5.54B | 945.81K shrs $69.66M | ||
| 138 |  Immunovant, Inc. IMVT🇺🇸USD | $31.11 | -4.78% | +1.38% | $6.39B €5.53B | 864.67K shrs $26.9M | |
| 139 | $97.38 | -5.26% | +5.22% | $6.26B €5.42B | 870.98K shrs $84.82M | ||
| 140 | $40.16 | -0.99% | -0.78% | $6.15B €5.33B | 1.75M shrs $70.28M | ||
| 141 | $39.62 | -0.45% | +1.20% | $6.13B €5.31B | 1.7M shrs $67.21M | ||
| 142 | ¥2293.00 | +0.35% | +1.23% | ¥912.44B $6.11B · €5.30B | 1.71M shrs ¥3.93B | ||
| 143 | $74.13 | -0.64% | +16.23% | $6.1B €5.28B | 632.02K shrs $46.85M | ||
| 144 | $26.19 | -6.50% | +13.99% | $6.06B €5.25B | 15.67M shrs $410.36M | ||
| 145 | $32.62 | -4.62% | +2.01% | $6.06B €5.25B | 2.48M shrs $81.04M | ||
| 146 | ¥1986.50 | +1.20% | +4.44% | ¥899.94B $6.03B · €5.22B | 1.47M shrs ¥2.93B | ||
| 147 | $86.40 | -1.38% | +3.97% | $5.93B €5.13B | 391.55K shrs $33.83M | ||
| 148 | $70.97 | +0.47% | -0.95% | $5.89B €5.10B | 937.08K shrs $66.5M | ||
| 149 | ¥33.59 | +0.12% | -0.70% | ¥42.47B $5.86B · €5.08B | 2.13M shrs ¥71.44M | ||
| 150 | ¥23.07 | +0.39% | +26.46% | ¥42.39B $5.85B · €5.07B | 27.94M shrs ¥644.62M | ||
| 151 | ¥116.27 | -2.80% | +28.05% | ¥41.96B $5.79B · €5.02B | 5.91M shrs ¥687.04M | ||
| 152 | Fr 68.55 | -1.79% | +14.25% | Fr 5.14B $5.75B · €4.98B | 87.97K shrs Fr 6.03M | ||
| 153 |  Belite Bio, Inc BLTE🇺🇸USD | $143.35 | -0.77% | -1.92% | $5.75B €4.98B | 291.54K shrs $41.79M | |
| 154 | ¥93.80 | -2.14% | +32.40% | ¥41.6B $5.74B · €4.97B | 1.37M shrs ¥128.78M | ||
| 155 | $93.48 | +1.07% | +8.45% | $5.7B €4.94B | 555.79K shrs $51.96M | ||
| 156 | ¥24.21 | +1.17% | -2.52% | ¥40.29B $5.56B · €4.82B | 6.48M shrs ¥156.98M | ||
| 157 | HK$16.23 | -0.06% | -2.52% | HK$43.34B $5.55B · €4.81B | 2.85M shrs HK$46.22M | ||
| 158 | $61.85 | -1.10% | +7.13% | $5.5B €4.76B | 1.69M shrs $104.74M | ||
| 159 | R$17.46 | -0.29% | -1.76% | R$30.53B $5.50B · €4.76B | — | ||
| 160 | kr 37.50 | +1.21% | -1.62% | kr 37.21B $5.43B · €4.71B | 83.9K shrs kr 3.15M | ||
| 161 | HK$70.50 | -2.62% | +11.31% | HK$41.99B $5.38B · €4.66B | 3.2M shrs HK$225.77M | ||
| 162 | $44.30 | -2.27% | +3.06% | $5.31B €4.60B | 1.14M shrs $50.45M | ||
| 163 | $31.02 | -5.40% | +5.98% | $5.3B €4.59B | 1.68M shrs $52.17M | ||
| 164 | ¥84.29 | +1.24% | +43.49% | ¥37.93B $5.23B · €4.53B | 4.16M shrs ¥350.54M | ||
| 165 | ¥21.44 | -1.65% | +20.55% | ¥37.78B $5.21B · €4.52B | 6.99M shrs ¥149.92M | ||
| 166 |  Grifols, S.A. GRFS🇺🇸USD | $7.64 | +0.79% | -1.39% | $5.2B €4.50B | 338.37K shrs $2.59M | |
| 167 | ₹761.95 | +2.20% | -0.39% | ₹428B $5.14B · €4.45B | 27.37K shrs ₹20.85M | ||
| 168 | ₹761.50 | +2.15% | -0.40% | ₹427.75B $5.13B · €4.45B | 264.76K shrs ₹201.62M | ||
| 169 | $51.84 | -8.97% | +3.02% | $5.11B €4.42B | 2.28M shrs $118.42M | ||
| 170 | 3SBio Inc. 1530.HK🇭🇰HKD | HK$15.68 | -1.88% | +4.97% | HK$39.21B $5.02B · €4.35B | 34.87M shrs HK$546.7M | |
| 171 | ₹1643.05 | +1.43% | +6.14% | ₹416.85B $5.00B · €4.33B | 17.69K shrs ₹29.06M | ||
| 172 | $51.73 | -2.38% | +10.42% | $5B €4.33B | 1.68M shrs $86.74M | ||
| 173 | ₹1641.90 | +1.73% | +6.20% | ₹416.56B $5.00B · €4.33B | 242.25K shrs ₹397.75M | ||
| 174 | ₩88100.00 | -2.65% | +0.00% | ₩6.9T $4.97B · €4.30B | 279.4K shrs ₩24.62B | ||
| 175 | ¥32.28 | +0.59% | +10.32% | ¥35.99B $4.97B · €4.30B | 20.77M shrs ¥670.53M | ||
| 176 | ₩50600.00 | -3.62% | -5.86% | ₩6.64T $4.78B · €4.14B | 849.13K shrs ₩42.97B | ||
| 177 | ¥37.53 | -5.49% | -6.24% | ¥34.49B $4.76B · €4.12B | 18.15M shrs ¥681.23M | ||
| 178 | ¥5.19 | +0.97% | -3.03% | ¥34.45B $4.75B · €4.12B | 33.55M shrs ¥174.12M | ||
| 179 | $237.00 | +0.46% | +11.66% | $4.75B €4.11B | 172.77K shrs $40.95M | ||
| 180 | $53.72 | -4.23% | +7.85% | $4.74B €4.10B | 939.81K shrs $50.49M | ||
| 181 | ¥25.03 | +0.72% | -1.52% | ¥34.33B $4.74B · €4.10B | 5.04M shrs ¥126.04M | ||
| 182 | ¥55.19 | -3.04% | +29.34% | ¥34.11B $4.71B · €4.08B | 6.99M shrs ¥385.51M | ||
| 183 | $16.49 | -4.57% | +6.53% | $4.66B €4.04B | 2.68M shrs $44.27M | ||
| 184 | NT$96.00 | -0.41% | -8.61% | NT$149.41B $4.63B · €4.01B | 4.27M shrs NT$409.71M | ||
| 185 | ₩494000.00 | +0.51% | +8.19% | ₩6.26T $4.51B · €3.91B | 546.09K shrs ₩269.77B | ||
| 186 | ₹2273.00 | +2.41% | +7.27% | ₹374.95B $4.50B · €3.90B | 494.41K shrs ₹1.12B | ||
| 187 | ₹2272.15 | +2.31% | +12.72% | ₹374.81B $4.50B · €3.90B | 30.4K shrs ₹69.08M | ||
| 188 | ₹2977.60 | +1.02% | — | ₹372.01B $4.46B · €3.87B | 5.24K shrs ₹15.6M | ||
| 189 | ₹2976.50 | +0.98% | +5.02% | ₹371.87B $4.46B · €3.87B | 108.1K shrs ₹321.76M | ||
| 190 | $37.62 | +0.44% | +0.73% | $4.45B €3.85B | 1.59M shrs $59.67M | ||
| 191 | ¥49.60 | +2.06% | +1.63% | ¥31.94B $4.41B · €3.82B | 7.37M shrs ¥365.77M | ||
| 192 | ₹2166.30 | -0.01% | — | ₹366.98B $4.40B · €3.81B | 2.38K shrs ₹5.16M | ||
| 193 | $80.51 | -4.30% | +3.06% | $4.4B €3.81B | 835.88K shrs $67.3M | ||
| 194 | ₹2164.10 | -0.12% | +4.30% | ₹366.61B $4.40B · €3.81B | 28.74K shrs ₹62.2M | ||
| 195 | $13.75 | +1.70% | +1.86% | $4.39B €3.80B | 1.25M shrs $17.19M | ||
| 196 | ¥1437.00 | +1.59% | +3.33% | ¥644.63B $4.32B · €3.74B | 4.2M shrs ¥6.04B | ||
| 197 | HK$93.50 | +2.24% | +11.82% | HK$33.74B $4.32B · €3.74B | 877.2K shrs HK$82.02M | ||
| 198 |  Celcuity Inc. CELC🇺🇸USD | $88.28 | -4.53% | +15.83% | $4.31B €3.73B | 1.66M shrs $146.28M | |
| 199 | ¥30.12 | -2.84% | +17.98% | ¥30.9B $4.26B · €3.69B | 14.33M shrs ¥431.65M | ||
| 200 | $45.81 | -0.80% | +0.70% | $4.26B €3.69B | 2.88M shrs $131.91M |
Browse by Country
Europe
Asia